References
- Alexanderson B., Sjöqvist F. Interaktion mellan läkemedel. FASS 1972, Almqvist & Wiksells Boktryckeri AB, Uppsala 1972; 707–809
- Alexanderson B., Sjövist F., Price Evans D. A. Steady-state plasma levels of nortriptyline in twins: Influence of genetic factors and drug therapy. Brit. Med. J. 1969; 4: 764–768
- Braithwaite R. A., Goulding R., Theano G., Bailey J., Coppen A. Plasma concentration of amitriptyline and clinical response. Lancet 1972; I: 1297–1300
- Curry S. H., Marshall J. H. L., Davis J. M., Janowsky D. S. Chlorpromazine plasma levels and effects. Arch. Gen. Psychiat. 1970; 22: 289–297
- Freyschuss U., Sjöqvist F., Tuck D. Tyramine pressor effects in man before and during treatment with nortriptyline or ECT: Correlation between pharmacokinetics and effect of nortriptyline. Eur. J. Clin. Pharmacol. 1970; 2: 72–78
- Gram L. F., Fredricson Overe K. Drug interaction: Inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man. Brit. Med. J. 1972; I: 463–465
- Mitchell J. R., Cavanaugh J. H., Arias L., Oates J. A. Guanethidine and related agents. III. Antagonism by drugs which inhibit the norepinephrine pump in man. J. Clin. Invest. 1970; 49: 1596–1604
- Sjöqvist F, Hammer W., Ideström C.-M., Lind M., Tuck D., Åsberg M. Plasma level of monomethylated tricyclic antidepressants and side-effects in man. Ex-cerpta Medica Intemat. Congr. Ser. 1968; 145: 246–257
- Sjöqvist F., Alexanderson B. Drug interactions–a critical look at their documentation and clinical importance. Excerpta med. internat. Congr. Ser. 1972; 105–117, No. 254
- Skinner C, Coull D. C., Johnston A. W. Antagonism of the hypotensive action of bethanidine and debrisoquine by tricyclic antidepressants. Lancet 1969; II: 564–566
- Svedmyr N. Potentieringsrisker vid tillforsel av katekolaminer till patienter som behandlas med tricykliska antidepressiva medel. Lakartidningen 1963; 65(Suppl. I)72–76
- Åsberg M., Cronholm B., Sjöqvist F., Tuck D. Relationship between plasma level and therapeutic effect of nortriptyline. Brit. Med. J. 1971; 3: 331–334